WallStreetZenWallStreetZen

NASDAQ: SPRO
Spero Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Spero Therapeutics revenue was $66.80M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $41.3M, up 658.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SPRO annual revenue was $66.8M, with 39.2% growth year-over-year.

SPRO past revenue growth

How has SPRO's revenue growth performed historically?

Company
39.24%
Industry
499.16%
Market
37.03%
SPRO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SPRO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SPRO's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SPRO revenue history

Current Revenue
$66.8M
Current Earnings
$8.6M
Current Profit Margin
12.8%

Be the first to know when SPRO announces revenue.

SPRO Revenue History By Year

SPRO Yearly RevenueSPRO RevenueSPRO ChangeSPRO Revenue Growth
2025-12-31$66.80M$18.83M+39.24%
2024-12-31$47.98M-$55.80M-53.77%
2023-12-31$103.78M$50.27M+93.95%
2022-12-31$53.51M$35.25M+193.10%
2021-12-31$18.26M$8.93M+95.67%
2020-12-31$9.33M-$8.82M-48.59%
2019-12-31$18.15M$14.18M+357.56%
2018-12-31$3.97M$1.99M+100.40%
2017-12-31$1.98M$1.64M+490.75%
2016-12-31$335.00kN/AN/A
2015-12-31$0.00N/AN/A

1 of 1

Spero Therapeutics Revenue FAQ

What was SPRO's revenue last quarter?

Spero Therapeutics (NASDAQ: SPRO) reported Q4 2025 revenue of $41.30 million up 174.51% year over year. In the same quarter last year, Spero Therapeutics's revenue was $15.04 million.

What was Spero Therapeutics's revenue in 2025?

Spero Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $66.80 million, a 39.24% increase year over year.

How much does Spero Therapeutics make in a day?

Based on Spero Therapeutics annual revenue for the past five years, SPRO makes an average of $159,082.19 per day.

What was Spero Therapeutics's annual revenue growth in the past year?

As of Q2 2026, Spero Therapeutics's revenue has grown 39.24% year over year. This is 459.93 percentage points lower than the US Biotechnology industry revenue growth rate of 499.16%. Spero Therapeutics's revenue in the past year totaled $66.80 million.

How much does Spero Therapeutics make in a year?

Spero Therapeutics's revenue by year for the past five years is:
  • Spero Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $66.80 million, a 39.24% increase year over year.
  • Spero Therapeutics's annual revenue for Dec 31, 2024 was $47.98 million, a 53.77% decrease from 2023.
  • Spero Therapeutics's annual revenue for 2023 was $103.78 million, a 93.95% increase from 2022.
  • Spero Therapeutics's annual revenue for 2022 was $53.51 million, a 193.1% increase from 2021.
  • Spero Therapeutics's annual revenue for 2021 was $18.26 million, a 95.67% increase from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.